×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [4]
Faculty of Healt... [4]
THE STATE KEY LA... [2]
INSTITUTE OF COL... [1]
Faculty of Scien... [1]
Authors
LEE MING YUEN [2]
HOI PUI MAN [2]
GE WEI [1]
KWOK HANG FAI [1]
ZHAO YONGHUA [1]
WANG RUIBING [1]
More...
Document Type
Journal article [7]
Date Issued
2024 [2]
2022 [1]
2021 [1]
2015 [1]
2010 [1]
2009 [1]
More...
Language
英語English [5]
Source Publication
Bioorganic and M... [1]
Computational an... [1]
International Jo... [1]
International Jo... [1]
International Jo... [1]
Journal of Cellu... [1]
More...
Indexed By
SCIE [6]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-7 of 7
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis.
Journal article
Wang MengFei, Yuan ChenYue, Wu Zong, Xu Meng, Chen ZiQi, Yao JiaLiang, Que ZuJun, Tian JianHui, Leung Elaine Lai Han, Wang ZiLiang. Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis.[J]. International Journal of Biological Sciences, 2024, 20(7), 2454-2475.
Authors:
Wang MengFei
;
Yuan ChenYue
;
Wu Zong
;
Xu Meng
;
Chen ZiQi
; et al.
Adobe PDF
|
Favorite
|
TC[WOS]:
1
TC[Scopus]:
1
IF:
8.2
/
8.3
|
Submit date:2024/06/10
Angiogenesis
Ecm1
Glycolysis
Ovarian Cancer
Paris Saponin Vii
Parpi Resistance
Rorα
Vegfr2
Extracellular Vesicles Maintain Blood-Brain Barrier Integrity by the Suppression of Caveolin-1/CD147/VEGFR2/MMP Pathway After Ischemic Stroke
Journal article
Yiyang Li, Jiali Chen, Xingping Quan, Ying Chen, Yan Han, Jinfen Chen, Li Yang, Youhua Xu, Xu Shen, Ruibing Wang, Yonghua Zhao. Extracellular Vesicles Maintain Blood-Brain Barrier Integrity by the Suppression of Caveolin-1/CD147/VEGFR2/MMP Pathway After Ischemic Stroke[J]. International Journal of Nanomedicine, 2024, 19, 1451-1467.
Authors:
Yiyang Li
;
Jiali Chen
;
Xingping Quan
;
Ying Chen
;
Yan Han
; et al.
Favorite
|
TC[WOS]:
3
TC[Scopus]:
2
IF:
6.6
/
7.5
|
Submit date:2024/04/03
Cd147
Caveolin-1
Vegfr2
Blood-brain Barrier
Extracellular Vesicles
Ischemic Stroke
Matrix Metalloproteinase
Murine Beta-Amyloid (1–42) Oligomers Disrupt Endothelial Barrier Integrity and VEGFR Signaling via Activating Astrocytes to Release Deleterious Soluble Factors
Journal article
Yue, Qian, Zhou, Xinhua, Zhang, Zaijun, Hoi, Maggie Pui Man. Murine Beta-Amyloid (1–42) Oligomers Disrupt Endothelial Barrier Integrity and VEGFR Signaling via Activating Astrocytes to Release Deleterious Soluble Factors[J]. International Journal of Molecular Sciences, 2022, 23(3), 1878.
Authors:
Yue, Qian
;
Zhou, Xinhua
;
Zhang, Zaijun
;
Hoi, Maggie Pui Man
Favorite
|
TC[WOS]:
9
TC[Scopus]:
10
|
Submit date:2022/03/04
Astrocytes
Blood–brain Barrier
Endothelial Cells
Murine Amyloid-beta
Tight Junctions
Vegfr2 Signaling Pathway
A novel bioengineered fragment peptide of Vasostatin-1 exerts smooth muscle pharmacological activities and anti-angiogenic effects via blocking VEGFR signalling pathway
Journal article
Wei, Ran, Wu, Qiushuang, Ai, Nana, Wang, Lei, Zhou, Mei, Shaw, Chris, Chen, Tianbao, Ye, Richard Dequan, Ge, Wei, Siu, Shirley W.I., Kwok, Hang Fai. A novel bioengineered fragment peptide of Vasostatin-1 exerts smooth muscle pharmacological activities and anti-angiogenic effects via blocking VEGFR signalling pathway[J]. Computational and Structural Biotechnology Journal, 2021, 19, 2664-2675.
Authors:
Wei, Ran
;
Wu, Qiushuang
;
Ai, Nana
;
Wang, Lei
;
Zhou, Mei
; et al.
Favorite
|
TC[WOS]:
5
TC[Scopus]:
5
IF:
4.4
/
5.0
|
Submit date:2021/09/17
Anti-angiogenesis
Chromogranin a
Vasostatin-1
Vegfr2
Recent advances in structure-based drug design and virtual screening of VEGFR tyrosine kinase inhibitors
Journal article
Pui Man Hoi, Shang Li, Chi Teng Vong, Hisa Hui Ling Tseng, Yiu Wa Kwan, Simon Ming-Yuen Lee. Recent advances in structure-based drug design and virtual screening of VEGFR tyrosine kinase inhibitors[J]. Methods, 2015, 71(C), 85-91.
Authors:
Pui Man Hoi
;
Shang Li
;
Chi Teng Vong
;
Hisa Hui Ling Tseng
;
Yiu Wa Kwan
; et al.
Favorite
|
TC[WOS]:
22
TC[Scopus]:
24
IF:
4.2
/
3.8
|
Submit date:2018/11/06
Molecular Docking
Pharmacophore Modeling
Vegfr2
Vegfr2 Inhibitors
Virtual Screening
Resveratrol derivative, trans-3,5,4′-trimethoxystilbene, exerts antiangiogenic and vascular-disrupting effects in zebrafish through the downregulation of VEGFR2 and cell-cycle modulation
Journal article
Deepa Alex, Emilia Conceição Leong, Zai-Jun Zhang, Gloria Tse Ho Yan, Shuk-Han Cheng, Chi-Weng Leong, Zhen-Hua Li, Kai-Heng Lam, Shun-Wan Chan, Simon Ming-Yuen Lee. Resveratrol derivative, trans-3,5,4′-trimethoxystilbene, exerts antiangiogenic and vascular-disrupting effects in zebrafish through the downregulation of VEGFR2 and cell-cycle modulation[J]. Journal of Cellular Biochemistry, 2010, 109(2), 339.
Authors:
Deepa Alex
;
Emilia Conceição Leong
;
Zai-Jun Zhang
;
Gloria Tse Ho Yan
;
Shuk-Han Cheng
; et al.
Favorite
|
TC[WOS]:
54
TC[Scopus]:
59
|
Submit date:2018/10/30
3,5,4′-trimethoxystilbene
Angiogenesis
Cell Cycle
Huvec
Vegfr2
Zebrafish
Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2
Journal article
Duncton M.A.J., Piatnitski Chekler E.L., Katoch-Rouse R., Sherman D., Wong W.C., Smith II L.M., Kawakami J.K., Kiselyov A.S., Milligan D.L., Balagtas C., Hadari Y.R., Wang Y., Patel S.N., Rolster R.L., Tonra J.R., Surguladze D., Mitelman S., Kussie P., Bohlen P., Doody J.F.. Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2[J]. Bioorganic and Medicinal Chemistry, 2009, 17(2), 731-740.
Authors:
Duncton M.A.J.
;
Piatnitski Chekler E.L.
;
Katoch-Rouse R.
;
Sherman D.
;
Wong W.C.
; et al.
Favorite
|
TC[WOS]:
38
TC[Scopus]:
38
|
Submit date:2019/01/16
Angiogenesis
Arylphthalazine
Inhibitor
Kdr
Kinase
Phthalazine
Vegfr-2